Back

Comparative analysis of antiarrhythmic drugs following atrial fibrillation ablation

9 April 2024 (08:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Poster session on ventricular tachycardia, others Antiarrhythmic Drug Treatment EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Antonio Rocha De Almeida

Hospital Espirito Santo de Evora, Evora (Portugal)

105 More presentations in this session

Presentation thumbnail
Clinical accuracy of a 3-dimensional multielectrode non-invasive ECG mapping vest in premature ventricular contraction ablation procedures
Associate Professor B. Hunuk (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Stereotactic arrhythmia radioablation for refractory ventricular tachycardia. A retrospective analysis and optimisation of the planning phase.
Mr J. Solana Munoz (Lausanne, CH)
Abstract
Presentation thumbnail
Electrophysiological characteristics of tachyarrhythmia and effects of catheter ablation in patients with Fontan circulation
Assistant Professor J. Uhm (Seoul, KR)
Abstract
Presentation thumbnail
Accuracy of pace-mapping using an automated template matching module for site of origin identification of idiopathic outflow tract premature ventricular contractions
Doctor N. Schaerli (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Epicardial catheter ablation of ventricular tachycardia in patients of acm - from a university hospital report in switzerland
Doctor F. Guan (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session on ventricular tachycardia, others

The Event

Event poster

EHRA 2024

9 April 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Incidence of systolic heart failure and need for implantable cardiac defibrillators in patients with atrial fibrillation who had catheter ablation versus antiarrhythmic medical therapy
thumbnail
Congress Session
Treatment of atrial fibrillation: there is more than ablation
thumbnail
Congress Presentation
Safety outcomes of catheter ablation versus antiarrhythmic drugs in atrial fibrillation: a comprehensive systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources